AMAlexander G. Marneros

Alexander G. Marneros

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander G. Marneros has a total of 131 co-authors. Here are the top co-authors by number of shared publications:

  • Bjorn R. Olsen

    Department of Developmental Biology Harvard School of Dental Medicine Department of Cell Biology Harvard Medical School Boston Massachusetts USA

    7 shared publications
  • Jackelyn R. Raymundo

    Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA

    5 shared publications
  • Bill Senapati

    Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA

    4 shared publications
  • Karin Strittmatter

    Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, USA

    4 shared publications
  • Ernst Reichenberger

    15Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT 06030, USA

    3 shared publications
  • Hui Zhang

    Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA

    3 shared publications

Latest Publications

  • KCTD1/KCTD15 complexes repress AP-2α and AP-2β to regulate neural crest–dependent craniofacial morphogenesis and scalp skin development

    by Jackelyn R. Raymundo, Bill Senapati, Wenjuan Zhu, Angela E. Lin, Luigi Vitagliano, Alexander G. Marneros

  • TGFα is required for hair follicle function during aging and its loss leads to progressive alopecia

    by Jackelyn R. Raymundo, Jasson Makkar, Michael G. Fasci, Ryan R. Driskell, Alexander G. Marneros


  • KCTD1/KCTD15-Mediated Repression of AP-2α/AP-2β Is Required for Proper Skin Appendage Development and Epidermal Homeostasis

    by Bill Senapati, Jackelyn R. Raymundo, Jasson Makkar, Ryan R. Driskell, Alexander G. Marneros


  • AP-2α/AP-2β Transcription Factors Are Key Regulators of Epidermal Homeostasis

    by Hui Zhang, Jackelyn R. Raymundo, Kathleen E. Daly, Wenjuan Zhu, Bill Senapati, Hanyu Zhong, Arjun R. Ahilan, Alexander G. Marneros


  • Open Access

    KCTD1/KCTD15 complexes control ectodermal and neural crest cell functions, and their impairment causes aplasia cutis

    by Jackelyn R. Raymundo, Hui Zhang, Giovanni Smaldone, Wenjuan Zhu, Kathleen E. Daly, Benjamin J. Glennon, Giovanni Pecoraro, Marco Salvatore, William A. Devine, Cecilia W. Lo, et al.

    Aplasia cutis congenita (ACC) is a congenital epidermal defect of the midline scalp and has been proposed to be due to a primary keratinocyte abnormality. Why it forms mainly at this anatomic site has remained a long-standing enigma. KCTD1 mutations cause ACC, ectodermal abnormalities, and kidney fibrosis, whereas KCTD15 mutations cause ACC and cardiac outflow tract abnormalities. Here, we found that KCTD1 and KCTD15 can form multimeric complexes and can compensate for each other’s loss and that disease mutations are dominant negative, resulting in lack of KCTD1/KCTD15 function. We demonstrated that KCTD15 is critical for cardiac outflow tract development, whereas KCTD1 regulates distal nephron function. Combined inactivation of KCTD1/KCTD15 in keratinocytes resulted in abnormal skin appendages but not in ACC. Instead, KCTD1/KCTD15 inactivation in neural crest cells resulted in ACC linked to midline skull defects, demonstrating that ACC is not caused by a primary defect in keratinocytes but is a secondary consequence of impaired cranial neural crest cells, giving rise to midline cranial suture cells that express keratinocyte-promoting growth factors. Our findings explain the clinical observations in patients with KCTD1 versus KCTD15 mutations, establish KCTD1/KCTD15 complexes as critical regulators of ectodermal and neural crest cell functions, and define ACC as a neurocristopathy.


  • Open Access

    AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis

    by Hui Zhang, Jackelyn Raymundo, Kathleen E. Daly, Wenjuan Zhu, Bill Senapati, Alexander G. Marneros

    AP-2 transcription factors regulate ectodermal development but their roles for epidermal homeostasis in the adult skin are unknown. We find that AP-2α is the predominant AP-2 family member in adult epidermis, followed by AP-2β. Through inactivation of AP-2α, AP-2β, or both in keratinocytes we assessed the effects of a gradient of epidermal AP-2 activity on skin function. We find that (1) loss of AP-2β in keratinocytes is compensated for by AP-2α, (2) loss of AP-2α impairs terminal keratinocyte differentiation and hair morphogenesis, and (3) the combined loss of AP-2α/AP-2β results in more severe skin and hair abnormalities. Keratinocyte differentiation defects precede a progressive neutrophilic skin inflammation. Inducible inactivation of AP-2α/AP-2β in the adult phenocopies these manifestations. Transcriptomic analyses of epidermis lacking AP-2α or AP-2α/AP-2β in keratinocytes demonstrate a terminal keratinocyte differentiation defect with upregulation of alarmin keratins and of several immune pathway regulators. Moreover, our analyses suggest a key role of loss of AP-2α-dependent gene expression of CXCL14 and KRT15 as an early pathogenic event towards the manifestation of skin inflammation. Thus, AP-2α/AP-2β are critical regulators of epidermal homeostasis in the adult skin.


  • Open Access

    Transcription factors AP-2α and AP-2β regulate distinct segments of the distal nephron in the mammalian kidney

    by Joseph O. Lamontagne, Hui Zhang, Alia M. Zeid, Karin Strittmatter, Alicia D. Rocha, Trevor Williams, Sheryl Zhang, Alexander G. Marneros

    Transcription factors AP-2α and AP-2β have been suggested to regulate the differentiation of nephron precursor populations towards distal nephron segments. Here, we show that in the adult mammalian kidney AP-2α is found in medullary collecting ducts, whereas AP-2β is found in distal nephron segments except for medullary collecting ducts. Inactivation of AP-2α in nephron progenitor cells does not affect mammalian nephrogenesis, whereas its inactivation in collecting ducts leads to defects in medullary collecting ducts in the adult. Heterozygosity for AP-2β in nephron progenitor cells leads to progressive distal convoluted tubule abnormalities and β-catenin/mTOR hyperactivation that is associated with renal fibrosis and cysts. Complete loss of AP-2β in nephron progenitor cells caused an absence of distal convoluted tubules, renal cysts, and fibrosis with β-catenin/mTOR hyperactivation, and early postnatal death. Thus, AP-2α and AP-2β have non-redundant distinct spatiotemporal functions in separate segments of the distal nephron in the mammalian kidney.


  • Epidermal growth factor deficiency predisposes to progressive renal disease

    by Alia M. Zeid, Joseph O. Lamontagne, Hui Zhang, Alexander G. Marneros

    Epidermal growth factor (EGF) is produced in the kidney by thick ascending limbs of the loop of Henle and by distal convoluted tubules (DCTs). Reduced urinary EGF levels have been associated with chronic kidney disease but it is not known whether physiological levels of EGF protect the kidney from progressive renal disease. Here, we show that EGF‐deficient mice on a mixed genetic background had increased urinary microalbumin, and a subset of these mice developed severe progressive renal disease with azotemia that was not seen in WT or TGFα‐deficient littermates with this mixed genetic background. These azotemic EGF‐deficient mice developed crescentic glomerulonephritis linked to HB‐EGF/EGFR hyperactivation in glomeruli, as well as attenuation of the proximal tubule brush border, distal convoluted tubule (DCT) dilatation, and kidney fibrosis associated with renal β‐catenin/mTOR hyperactivation. The observation of these severe renal pathologies only in a subset of EGF‐deficient mice suggests that independent segregation of strain‐specific modifier alleles contributes to the severity of the renal abnormalities that only manifest when EGF is lacking. These findings link the lack of EGF to renal pathologies in the adult mammalian kidney, in support of a role of physiological levels of EGF for maintaining the function of glomeruli, proximal tubules, and DCTs. These observations suggest that diminished EGF levels predispose kidneys to progressive renal disease.


  • Open Access

    Role of inflammasome activation in neovascular age‐related macular degeneration

    by Alexander G. Marneros

    Current anti‐VEGF‐A therapies inhibit choroidal neovascularization (CNV) in a subset of patients with neovascular age‐related macular degeneration (NV‐AMD). However, long‐term treatment with such anti‐VEGF‐A therapies may impair physiological functions of the choriocapillaris and retina for which VEGF‐A is needed. Moreover, disease progression can occur despite continuous anti‐VEGF‐A treatment. Thus, novel therapies for NV‐AMD are urgently needed that target specifically disease‐associated mechanisms without impairing growth factors and cellular pathways that are required for homeostatic functions of the retina and choroid. Inhibiting the inflammatory pathways that promote CNV would be such a promising novel approach that would likely not interfere with the normal functions of healthy retinal and choroidal cells. In this context, the inflammasome, a proinflammatory protein complex that promotes pathologic angiogenesis largely through generation of IL‐1β and which has been reported to be activated in AMD, has become an area of much interest in the AMD field. However, most studies have focused mainly on the NLRP3 inflammasome in retinal pigment epithelial cells (RPE), and conflicting findings have resulted in an unclear picture of the role of the inflammasome for AMD pathogenesis. Recent data suggest that inflammasome activation in activated macrophages and retinal microglia but not in RPE cells promotes CNV. Furthermore, inflammasome activation can occur in CNV macrophages and microglia despite lack of NLRP3. Thus, activation of both NLRP3 inflammasomes as well as non‐NLRP3 inflammasomes in macrophages/microglia at sites of CNV formation likely promote NV‐AMD.